Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03233594
Other study ID # 17D.163
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date June 7, 2017
Est. completion date April 1, 2024

Study information

Verified date July 2023
Source Thomas Jefferson University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Central nervous system (CNS) changes associated with pain have been difficult to measure until the development of functional neuroimaging techniques such as positron emission tomography (PET). We have previously observed asymmetry in the thalamus associated with chronic pain that altered during acupuncture therapy. Imaging studies of therapeutic techniques for chronic pain in animals and humans have been quite limited. This study will be the first to utilize FDG PET-MRI imaging of both the brain and body in order to assess CNS changes and peripheral body changes related to chronic pain and its potential management.


Description:

The proposed study is based on our growing understanding of chronic pain and our ability to use functional brain imaging to study in vivo neurophysiologic processes. It is important to understand the brain and body mechanisms of chronic pain in order to better determine therapeutic interventions to reduce pain. Part of the difficulty in treating chronic pain is to determine how better to diagnose what specific issues are affecting the brain and body that result in chronic pain. Participants will undergo a small battery of diagnostic tests that include magnetic resonance imaging (MRI), positron emission tomography (PET). A secondary goal of this study is to determine if undergoing chiropractic care alters body or brain physiology in patients with chronic pain.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 32
Est. completion date April 1, 2024
Est. primary completion date April 1, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria for Chronic Pain Patients: - Age greater than 18 years old. - Have chronic pain symptoms for >3 months; - Have moderate pain (>3/10) in 2 or more areas for more than 5 out of 7 days - Is planning on undergoing chiropractic care for the clinical management of the chronic pain. - May be on pain medications provided that they are on a stable dose for at least 1 month - Patients have no other pre-existing and active significant medical, neurological, or psychological disorders. - Minor, stable health problems that should have no substantial effect on cerebral blood flow will be allowed (i.e. controlled hypertension, medication controlled diabetes). - Patients will be allowed to be taking medications or supplements at the initial intake, but they must be on a stable dose regimen for at least 1 month. - Able to give informed consent and willing to complete the study at Thomas Jefferson University and Marcus Institute of Integrative Health. Inclusion Criteria for Healthy Controls: - No significant current active medical conditions. - Stable medical conditions as determined by the PI are allowed. - No brain or body abnormalities that would affect the acquisition or analysis of the scan. Exclusion Criteria for Chronic Pain Patients and Healthy Controls: - Pregnant or breast feeding - Enrollment in active clinical trial/ experimental therapy within the prior 30 days. - Subject is unable or unwilling to lie still in the scanner (i.e. due to claustrophobia or weight) - Subject has metal in their body or other reason that they cannot undergo magnetic resonance imaging.

Study Design


Intervention

Other:
Chiropractic Group
Participants will receive approximately 8 weeks of chiropractic care.
Healthy Control Group
Participants will not receive any interventions.

Locations

Country Name City State
United States Thomas Jefferson University, Marcus Institute of Integrative Health Centers Philadelphia Pennsylvania
United States Thomas Jefferson University, Marcus Institute of Integrative Health Centers Villanova Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
Thomas Jefferson University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Brief Pain Inventory Questionnaire This validated questionnaire will be used as one of the evaluation questionnaires for the study. Baseline and 8 weeks
Other Numeric Rating Scale for Pain Intensity for specific locations This validated questionnaire will be used as one of the evaluation questionnaires for the study. Baseline and 8 weeks
Other Profile of Mood Scale The Profile of Mood States (POMS) is a validated questionnaire of 65 single word items that asks "How have you been feeling in the past week including today." The subjects will select their response to each word that describes a mood or feeling on a Likert scale from 1= Not at All, 2= A Little, 3=Moderately, 4=Quite a lot, to 5=Extremely. The responses are scored to generate values for Tension, Anger, Confusion, Depression and Vigor. The higher scores indicate a greater presence of that mood or state. Baseline and 8 weeks
Other Patient-Reported Outcomes Measurement Information System (PROMIS) for quality of life assessment This validated questionnaire will be used as one of the evaluation questionnaires for the study. Baseline and 8 weeks
Primary Use combined PET/MRI to define pain activity pattern and inflammation. To use PET-MRI to define abnormal brain and body activity and evaluate changes in inflammation in painful regions in patients with chronic pain syndromes. Baseline and 8 weeks
Secondary Use combined PET/MRI to demonstrate brain and body activity in responders and non-responders. Patterns will be compared between those who respond and those who do not respond to chiropractic care. Baseline and 8 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT01417923 - The Immune and Clinical Impacts of Vitamin D in Patients With Chronic Musculo-skeletal Pain Phase 4
Completed NCT03472521 - Prevention of Persistent Opioid Use in Mothers Phase 4
Not yet recruiting NCT03249025 - Lidocaine-Ketamine for Management of Chronic Pain N/A
Enrolling by invitation NCT06359561 - Assessment of Effectiveness and Stimulation Coverage of Closed-loop Spinal Cord Stimulation (CL-SCS) Therapy in Patients With Cervical Lead Placement
Recruiting NCT05877274 - Sodium Channel Mutations in Patient With the Anterior Cutaneous Nerve Entrapment Syndrome (ACNES)
Completed NCT03317782 - NoL Index Variations Before and After a Stellate Ganglion Block
Completed NCT04199858 - Electrophysiological Correlates of Nocebo Effects on Pain N/A
Recruiting NCT05491499 - Assessing the Impact of Exercise Based Intensive Interdisciplinary Pain Treatment (IIPT) on Endogenous Pain Modulation in Youth With Chronic Pain Syndromes
Active, not recruiting NCT05090683 - Evaluation of a Mind-body Based Application for the Treatment of Chronic/Persistent Pain. N/A
Completed NCT04197154 - Pain-related Fear as a Facilitator of Nocebo Hyperalgesia N/A
Completed NCT04209764 - Prevalence of Pain in the Departments of Surgery and Oncoematology of a Children's Hospital
Recruiting NCT06072001 - Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis Phase 3
Recruiting NCT06071949 - Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis Phase 3
Recruiting NCT06071962 - Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Back Pain Phase 3
Recruiting NCT06071936 - Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy Phase 3
Recruiting NCT06072560 - Efficacy and Tolerability of AP707 in Patients With Chronic Back Pain Phase 3
Recruiting NCT06071988 - Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy Phase 3
Recruiting NCT06071975 - Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy Phase 3
Recruiting NCT06072573 - Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy Phase 3
Completed NCT03460717 - Thermal Micro-cautery for Painful Knee Osteoarthritis N/A